Stock search

Ticker or company name

TECH card

TECH price forecast

Bio-Techne$72,79

P/E now is 66,8. Average over 5 years: 70,1 (range 50–79). The stock is 5% below its history.

Base · FY2031

$123,17+12,5% a year

The base case gives 12,5% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2027FY2028FY2029FY2030FY2031
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$1,28 bn$1,35 bn$1,43 bn$1,50 bn$1,59 bn
Net income$216 m$228 m$241 m$254 m$268 m
EPS$1,39$1,47$1,56$1,66$1,76

Changed values are highlighted. Bear and bull cases: growth ∓ 7,6%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $72,79

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2031

Bear$53,33

Price change
−26,7%
A year
−6,0%
Fair value today
$35,25
Margin of safety
−51,6%

Base$123,17

Price change
+69,2%
A year
+12,5%
Fair value today
$80,63
Margin of safety
+10,8%

Bull$220,36

Price change
+202,7%
A year
+27,5%
Fair value today
$143,77
Margin of safety
+97,5%

What growth the price implies

For the stock to return 10% a year, revenue must grow 3,7% a year to FY2031 at a 16,9% margin and P/E 70,1.

Growth over 5 years
5,5%
Analyst consensus
no data
In your model
5,5%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2031$123,17+12,5% a year